SomnoMed Limited
SOMNF
$0.4361
-$0.0487-10.05%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.14% | 10.31% | 6.75% | 6.88% | 7.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.14% | 10.31% | 6.75% | 6.88% | 7.98% |
| Cost of Revenue | 17.21% | 15.60% | 12.24% | 9.54% | 7.77% |
| Gross Profit | 8.99% | 7.05% | 3.41% | 5.24% | 8.11% |
| SG&A Expenses | 2.14% | 7.34% | 11.42% | 10.58% | 10.66% |
| Depreciation & Amortization | 1.86% | 6.41% | 9.90% | 15.54% | 23.08% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.52% | 10.26% | 11.63% | 10.48% | 10.27% |
| Operating Income | 60.75% | -9.46% | -124.76% | -91.78% | -60.49% |
| Income Before Tax | 56.92% | 9.07% | -55.73% | -82.86% | -132.45% |
| Income Tax Expenses | 125.35% | 71.60% | 15.24% | -12.68% | -32.67% |
| Earnings from Continuing Operations | 43.24% | 2.05% | -51.52% | -68.59% | -96.32% |
| Earnings from Discontinued Operations | -- | -- | -- | 52.42% | -60.26% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.74% | 3.24% | -49.01% | -66.86% | -95.92% |
| EBIT | 60.75% | -9.46% | -124.76% | -91.78% | -60.49% |
| EBITDA | 104.74% | 8.78% | -183.21% | -143.45% | -104.04% |
| EPS Basic | 67.12% | 34.90% | -2.77% | -31.76% | -77.02% |
| Normalized Basic EPS | 72.10% | 36.67% | -6.63% | -41.04% | -97.46% |
| EPS Diluted | 67.12% | 34.90% | -2.77% | -31.76% | -77.02% |
| Normalized Diluted EPS | 72.10% | 36.67% | -6.63% | -41.04% | -97.46% |
| Average Basic Shares Outstanding | 108.63% | 82.40% | 53.66% | 31.64% | 9.60% |
| Average Diluted Shares Outstanding | 108.63% | 82.40% | 53.66% | 31.64% | 9.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |